T1	Participants 61 125	patients with hepatitis B e antigen-negative chronic hepatitis B
T2	Participants 210 235	chronic hepatitis B (CHB)
T3	Participants 458 499	Thirteen patients with HBeAg-negative CHB
T4	Participants 279 321	hepatitis B e antigen (HBeAg)-negative CHB
T5	Participants 1522 1540	HBeAg-negative CHB
